CVB MEDICAL: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
CVB MEDICAL
Largest movements
- Cash -€70,897
down €70,897 (-41.5%), from €170,970 to €100,073
mainly Other debts (-€207,076) and Tax, wage and social debts (-€5,415)
- Intangible fixed assets -€37,700
down €37,700 (-11.8%), from €320,450 to €282,750
- Other debts -€207,076
down €207,076 (-61.1%), from €339,017 to €131,941
- Profit (loss) carried forward +€103,262
up €103,262 (+69.9%), from €147,628 to €250,891
- Tax, wage and social debts -€5,415
down €5,415 (-62.7%), from €8,630 to €3,215
of which Taxes: -€3,415
- Gross operating margin +€9,086
up €9,086 (+5.6%), from €162,540 to €171,627
- Taxes +€2,585
up €2,585 (+10.1%), from €25,630 to €28,215
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €498,775 | €389,547 | -€109,229 | -21.9% |
| Fixed assets | 21/28 | €324,562 | €286,628 | -€37,934 | -11.7% |
| Intangible fixed assets | 21 | €320,450 | €282,750 | -€37,700 | -11.8% |
| Tangible fixed assets | 22/27 | €4,112 | €3,878 | -€234 | -5.7% |
| Plant, machinery and equipment | 23 | €4,112 | €3,878 | -€234 | -5.7% |
| Current assets | 29/58 | €174,214 | €102,919 | -€71,294 | -40.9% |
| Cash at bank and in hand | 54/58 | €170,970 | €100,073 | -€70,897 | -41.5% |
| Deferred charges and accrued income | 490/1 | €3,244 | €2,846 | -€397 | -12.2% |
| Total equity and liabilities | 10/49 | €498,775 | €389,547 | -€109,229 | -21.9% |
| Equity | 10/15 | €151,128 | €254,391 | +€103,262 | +68.3% |
| Contributions | 10/11 | €3,500 | €3,500 | = | 0.0% |
| Profit (loss) carried forward | 14 | €147,628 | €250,891 | +€103,262 | +69.9% |
| Amounts payable | 17/49 | €347,647 | €135,156 | -€212,491 | -61.1% |
| Amounts payable within one year | 42/48 | €347,647 | €135,156 | -€212,491 | -61.1% |
| Taxes, remuneration and social security | 45 | €8,630 | €3,215 | -€5,415 | -62.7% |
| Taxes | 450/3 | €6,630 | €3,215 | -€3,415 | -51.5% |
| Remuneration and social security | 454/9 | €2,000 | - | -€2,000 | |
| Other amounts payable | 47/48 | €339,017 | €131,941 | -€207,076 | -61.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €37,934 | €37,934 | = | 0.0% |
| Other operating charges | 640/8 | €3,012 | €1,806 | -€1,206 | -40.1% |
| Gross operating margin | 9900 | €162,540 | €171,627 | +€9,086 | +5.6% |
| Operating profit (loss) | 9901 | €121,594 | €131,887 | +€10,293 | +8.5% |
| Financial income | 75/76B | - | €0 | +€0 | |
| Recurring financial income | 75 | - | €0 | +€0 | |
| Financial charges | 65/66B | €337 | €410 | +€73 | +21.6% |
| Recurring financial charges | 65 | €337 | €410 | +€73 | +21.6% |
| Profit (loss) for the period before taxes | 9903 | €121,257 | €131,477 | +€10,220 | +8.4% |
| Income taxes | 67/77 | €25,630 | €28,215 | +€2,585 | +10.1% |
| Profit (loss) for the period | 9904 | €95,627 | €103,262 | +€7,635 | +8.0% |
| Profit (loss) for the period to be appropriated | 9905 | €95,627 | €103,262 | +€7,635 | +8.0% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 October 2026 via checked.be.